[go: up one dir, main page]

AU2001218024A1 - Methods for treating and preventing alopecia - Google Patents

Methods for treating and preventing alopecia

Info

Publication number
AU2001218024A1
AU2001218024A1 AU2001218024A AU1802401A AU2001218024A1 AU 2001218024 A1 AU2001218024 A1 AU 2001218024A1 AU 2001218024 A AU2001218024 A AU 2001218024A AU 1802401 A AU1802401 A AU 1802401A AU 2001218024 A1 AU2001218024 A1 AU 2001218024A1
Authority
AU
Australia
Prior art keywords
treating
methods
preventing alopecia
alopecia
preventing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001218024A
Inventor
Gere S. Dizerega
Kathleen E. Roders
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southern California USC
Original Assignee
University of Southern California USC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southern California USC filed Critical University of Southern California USC
Publication of AU2001218024A1 publication Critical patent/AU2001218024A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001218024A 2000-06-19 2000-11-27 Methods for treating and preventing alopecia Abandoned AU2001218024A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21260800P 2000-06-19 2000-06-19
US60212608 2000-06-19
PCT/US2000/032340 WO2001098325A1 (en) 2000-06-19 2000-11-27 Methods for treating and preventing alopecia

Publications (1)

Publication Number Publication Date
AU2001218024A1 true AU2001218024A1 (en) 2002-01-02

Family

ID=22791736

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001218024A Abandoned AU2001218024A1 (en) 2000-06-19 2000-11-27 Methods for treating and preventing alopecia

Country Status (3)

Country Link
EP (1) EP1292610A1 (en)
AU (1) AU2001218024A1 (en)
WO (1) WO2001098325A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004304716B2 (en) 2003-12-18 2010-05-27 Biomas Ltd. Tellurium derivatives for prevention and treatment of neurodegenerative processes
WO2006030439A2 (en) 2004-09-17 2006-03-23 Biomas Ltd. Compositions and methods for inducing hair growth
AT508569A1 (en) * 2009-07-23 2011-02-15 Affiris Ag PHARMACEUTICAL COMPOUND
AU2012212220B2 (en) * 2011-02-02 2013-04-04 University Of Southern California Methods for treating diabetic foot ulcers
US8557958B1 (en) 2012-06-18 2013-10-15 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of diabetes
US8633158B1 (en) 2012-10-02 2014-01-21 Tarix Pharmaceuticals Ltd. Angiotensin in treating brain conditions
WO2014078929A1 (en) * 2012-11-26 2014-05-30 Universidade Federal De Minas Gerais - Ufmg Topical formulation for the prevention and treatment of alopecia and for inhibiting hair growth
US9333233B2 (en) 2014-02-25 2016-05-10 Tarix Pharmaceuticals Ltd. Methods and compositions for the delayed treatment of stroke

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567679A (en) * 1993-12-13 1996-10-22 Daly; Theodore J. Use of CGRP in treating alopecia
US5753226A (en) * 1995-04-11 1998-05-19 The Trustees Of The University Of Pennsylvania Methods of enhancing epithelial cell proliferation
US5804445A (en) * 1996-01-11 1998-09-08 Board Of Regents, The University Of Texas System High affinity mutants of nuclear factor-interleukin 6 and methods of use therefor
JP3567350B2 (en) * 1996-03-13 2004-09-22 株式会社ホーネンコーポレーション Anti-alopecia

Also Published As

Publication number Publication date
EP1292610A1 (en) 2003-03-19
WO2001098325A1 (en) 2001-12-27

Similar Documents

Publication Publication Date Title
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AU2002219945A1 (en) Composition and method for treating snoring
AU2001253065A1 (en) Compositions and methods for treating hair loss using oximyl- and hydroxylamino-prostaglandins
AU7883700A (en) Methods and apparatus for treating teeth
AU2373200A (en) Apparatuses and methods for forming assemblies
AU2001284865A1 (en) Methods for diagnosing and treating dysautonomia and other dysautonomic conditions
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
EP1337208A4 (en) Methods and devices for treating stuttering problems
AU2002236626A1 (en) Compositions and methods for treating hyperpigmentation
AU2001279850A1 (en) Method and arrangement for studsystem
AU5838700A (en) Method for treating and preventing finger disorders
AU2001262978A1 (en) Method and apparatus for interference reduction
AU2001263516A1 (en) Glare reduction system and method
AU2001243394A1 (en) Compounds and methods
GB0014185D0 (en) Compound and method
AU2001229471A1 (en) Apparatus and method for hair treatment
AUPQ872300A0 (en) Compounds and methods
AU2001233581A1 (en) Process for reserving and treating urine
AU2001218024A1 (en) Methods for treating and preventing alopecia
AU2001261193A1 (en) Integrated security system and method
AU2001278951A1 (en) Compounds and methods
AU2002211359A1 (en) Stem cell-based methods for preventing and treating tumor
AU2001238179A1 (en) Method and compositions for treating hepatocellular cancer
AU2001261513A1 (en) Composition and method for increasing testosterone levels